603233 DaShenLin Pharmaceutical Group
- 15.94
- +1.45+10.01%
DaShenLin Pharmaceutical Group News
Dashanlin: Dashanlin Pharmaceutical Group Co., Ltd. Third Quarter Report 2024
Announcement of Dashenlin Pharmaceutical Group Co., Ltd. on the main operating data for the third quarter of 2024
Dashenlin Pharmaceutical Group Co., Ltd. Report for the third quarter of 2024
Dashenlin Pharmaceutical Group Co., Ltd. 2024 Semi-Annual Report
Summary of the 2024 semi-annual report of Dashenlin Pharmaceutical Group Co., Ltd.
Summary of the 2023 Annual Report of Dashenlin Pharmaceutical Group Co., Ltd.
Dashenlin Pharmaceutical Group Co., Ltd. 2023 Annual Report
Dashenlin Pharmaceutical Group Co., Ltd. Report for the first quarter of 2024
Dashenlin Pharmaceutical Group Co., Ltd. 2023 Third Quarter Report
Summary of the 2023 semi-annual report of Dashenlin Pharmaceutical Group Co., Ltd.
Semi-annual Report of Dashenlin Pharmaceutical Group Co., Ltd. 2023
Dashanlin Pharmaceutical Group Co., Ltd. 2022 Annual Report
Dashanlin Pharmaceutical Group Co., Ltd. report for the first quarter of 2023
Summary of the 2022 Annual Report of Dashanlin Pharmaceutical Group Co., Ltd.
Dashenlin: Dashenlin Pharmaceutical Group Co., Ltd.'s third quarter report
Dashenlin Pharmaceutical Group Co., Ltd. 2022 Third Quarter Report
Dashenlin: Dashenlin Pharmaceutical Group Co., Ltd.\'s performance forecast for the first three quarters of 2022
Dashanlin Pharmaceutical Group Co., Ltd. performance forecast for the first three quarters of 2022
Dashenlin: Dashenlin Pharmaceutical Group Co., Ltd. Semi-Annual Report 2022
Dashenlin: Summary of the 2022 semi-annual report of Dashenlin Pharmaceutical Group Co., Ltd.
Analysis
Price Target
No Data
No Data